BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

514 hedge funds and large institutions have $16.1B invested in BioMarin Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 191 increasing their positions, 187 reducing their positions, and 76 closing their positions.

Holders
514
Holders Change
-39
Holders Change %
-7.05%
% of All Funds
8.2%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.22%
New
43
Increased
191
Reduced
187
Closed
76
Calls
$139M
Puts
$86.9M
Net Calls
+$52.3M
Net Calls Change
+$62.2M

Top Buyers

1
Barclays
1
Barclays
United Kingdom
$493M
2
Nomura Holdings
2
Nomura Holdings
Japan
$251M
3
Pictet Asset Management
3
Pictet Asset Management
Switzerland
$172M
4
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
$80.3M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$80.6M

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$212M
2
CG
2
Carmignac Gestion
France
$8.93K
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$532M
4
Deutsche Bank
4
Deutsche Bank
Germany
$124M
5
Invesco
5
Invesco
Georgia
$39.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$1.63B 18,406,539 +22,920 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.57B 17,701,210 -40,496 -0.2%
BlackRock
3
BlackRock
New York
$1.29B 14,607,187 +591,722 +4%
Dodge & Cox
4
Dodge & Cox
California
$1.25B 14,153,503 -136,800 -1%
State Street
5
State Street
Massachusetts
$571M 6,458,729 +505,045 +8%
Capital Research Global Investors
6
Capital Research Global Investors
California
$532M 6,017,970 -738,062 -11%
Barclays
7
Barclays
United Kingdom
$493M 5,573,157 +2,911,886 +109%
Ameriprise
8
Ameriprise
Minnesota
$457M 5,163,949 +275,436 +6%
Viking Global Investors
9
Viking Global Investors
Connecticut
$373M 4,215,456 +58,671 +1%
ACA
10
Avoro Capital Advisors
New York
$341M 3,850,000 -150,000 -4%
BBA
11
Baker Bros. Advisors
New York
$337M 3,810,248 – –
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$303M 3,424,539 +34,893 +1%
Norges Bank
13
Norges Bank
Norway
$269M 3,043,300 +6,801 +0.2%
Nomura Holdings
14
Nomura Holdings
Japan
$251M 2,840,810 +2,840,810 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$244M 2,762,436 +51,411 +2%
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$232M 2,618,832 +7,515 +0.3%
Bank of America
17
Bank of America
North Carolina
$212M 2,395,221 -1,264,919 -35%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$212M 2,395,140 +207,665 +9%
Parnassus Investments
19
Parnassus Investments
California
$207M 2,338,529 – –
Pictet Asset Management
20
Pictet Asset Management
Switzerland
$172M 1,942,245 +1,942,245 New
PAI
21
Palo Alto Investors
California
$162M 1,831,035 – –
O
22
OrbiMed
New York
$143M 1,615,210 – –
Deutsche Bank
23
Deutsche Bank
Germany
$124M 1,398,719 -596,287 -30%
FWIA
24
Fort Washington Investment Advisors
Ohio
$116M 1,308,245 +126,680 +11%
Charles Schwab
25
Charles Schwab
California
$115M 1,304,797 +33,592 +3%
1
2 3 4 5